Fierce Pharma

DECEMBER 13, 2023

Using Tuesday to announce good news—that its $43 billion acquisition of Seagen would be | Using Tuesday to announce good news—that its $43 billion acquisition of Seagen would be finalized on Thursday—Pfizer sandwiched its bad news, which came on Wednesday with its 2024 guidance. The company expects revenue to reach between $58.5 billion and $61.5 billion next year, coming up short of the analyst consensus of $63.2 billion, largely because of the plummeting demand for its COVID-19 products.

Sales 361

Sales 361

MedCity News

DECEMBER 13, 2023

Health systems have been increasingly dropping MA contracts, saying that they cause their organizations to lose too much money and result in dangerous patient care delays. To mitigate this issue, experts think large MA plans need to delegate more utilization management duties to health systems rather than handling it themselves.

Management 140

Management Patients 140

Fierce Pharma

DECEMBER 13, 2023

After wrapping up a $200 million renovation at a former Boehringer Ingelheim plant near Cleveland, Ohio, several years back, Danish specialty drugmaker Xellia Pharmaceuticals is paring back its wor | After wrapping up a $200 million renovation at a former Boehringer Ingelheim plant near Cleveland, Ohio, several years back, Danish specialty drugmaker Xellia Pharmaceuticals is paring back its workforce in The Forest City.

Pharmaceutical 220

Pharmaceutical 220

MedCity News

DECEMBER 13, 2023

Google introduced a new suite of healthcare-focused generative AI models designed to speed up workflows for clinicians and medical researchers. Health systems and medical research organizations, including HCA Healthcare and BenchSci, have been testing these models since April.

Healthcare 125

Healthcare Healthcare Medical 125

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmExec

DECEMBER 13, 2023

Lisa Conte, founder, president, and CEO of Jaguar Health, discusses how a climb up Mount Kilimanjaro would vault her to her true career calling—and spark a decades-long quest to accelerate breakthroughs in plant-based pharmaceuticals and supportive care.

Pharmaceutical 115

Pharmaceutical 115

MedCity News

DECEMBER 13, 2023

About eight in 10 employers think drug costs, high-cost claims and hospital prices are a “significant threat to affordability,” according to a new survey from National Alliance of Healthcare Purchaser Coalitions.

Healthcare 126

Healthcare Healthcare 126

MedCity News

DECEMBER 13, 2023

With the Centers for Medicare & Medicaid Services (CMS) releasing annual changes that impact all facets of the MA Star Ratings program, health systems and providers need to stay ahead of these changes and navigate them effectively by leveraging technology that can guide and optimize the complete patient journey.

Patients 113

Patients 113

PharmExec

DECEMBER 13, 2023

Current industry challenges present an opportunity for innovation and the adoption of new solutions, particularly in addressing barriers related to patient recruitment, engagement, and retention.

Recruitment 98

Recruitment Patients 98

MedCity News

DECEMBER 13, 2023

When it comes to organizational growth, the concept of “growth by any means” is hurting the hospital’s bottom line and pushing healthcare to a tipping point – adding expense to American healthcare without adding value.

Marketing 106

Marketing Healthcare Healthcare 106

Pharmaceutical Technology

DECEMBER 13, 2023

Advanced simulation methods and tools are not only paving the way for more efficient manufacturing operations. At SHL Medical, they’re also speeding up the development of new production facilities around the globe.

Manufacturing 98

Manufacturing Medical 98

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

PharmaVoice

DECEMBER 13, 2023

Dr. Julie Gerberding, now president and CEO of the Foundation for the National Institutes of Health, shares lessons learned from a long career in academic, public health and industry.

97

97

European Pharmaceutical Review

DECEMBER 13, 2023

Bristol Myers Squibb has entered an exclusive license and collaboration agreement for SystImmune’s BL-B01D1, a potentially first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC). As part of the potential $8.4 billion deal the companies will jointly commercialise BL-B01D1 in the United States. Bristol Myers Squibb will also assume sole responsibility for development and commercialisation of the ADC in the rest of the world, outside of Mainland China.

Manufacturing 95

Manufacturing Safety Medical Medicine 95

Pharmaceutical Commerce

DECEMBER 13, 2023

The seminar examines where members of the pharma supply chain stand in terms of preparation, being that the act has officially been enacted.

Pharma 105

Pharma 105

pharmaphorum

DECEMBER 13, 2023

Eisai and Biogen’s Alzheimer’s disease therapy Leqembi is due to be launched in Japan, its second market, on 20th December, and will be priced quite a lot lower there than in the US. The anti-amyloid antibody has been included in the Japan National Health Insurance (NHI) Drug Price List at just under JPY 3 million (around $20,500) per patient per year, whereas in the US its list price before discounts or rebates was set at $26,500.

Insurance 94

Insurance Marketing Patients 94

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTimes

DECEMBER 13, 2023

In England, ruptured brain aneurysms occur in around one in 15,000 people every year - News - PharmaTimes

Safety 113

Safety 113

MedCity News

DECEMBER 13, 2023

The panelists for the digital flywheel in healthcare discussion included: Sara Vaezy of Providence; Justin Dearborn of Praia Health, Providence Digital Innovation Group; and Sonia Singh of AVIA, who served as the moderator.

Patients 94

Patients Healthcare Healthcare CRM 94

PharmaTimes

DECEMBER 13, 2023

The software has reduced the time to provide pathology data from days to hours - News - PharmaTimes

106

106

pharmaphorum

DECEMBER 13, 2023

Pharnext hit again as rare disease drug flunks phase 3 test Phil.

115

115

Advertisement

PharmExec

DECEMBER 13, 2023

How drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve.

Healthcare Provider 64

Healthcare Provider Healthcare Healthcare Patients 64

European Pharmaceutical Review

DECEMBER 13, 2023

The European Commission has approved Blueprint Medicines’ Ayvakyt® (avapritinib) for treatment of adult patients with the haematological disorder indolent systemic mastocytosis (ISM). “Ayvakyt represents an important treatment breakthrough as the first medicine approved for patients living with ISM, and the only therapy designed to selectively target the primary genetic driver of the disease,” declared Jens Panse, Deputy Director of the Department of Haematology/Oncology of the University Hospit

Medicine 64

Medicine Safety Patients Healthcare 64

Eversana Intouch

DECEMBER 13, 2023

In the dynamic realm of digital marketing, leveraging first-party and third-party cookies is akin to navigating uncharted territories. And while these data sources have long been the bedrock of digital strategies, the landscape has drastically shifted with the surge in privacy legislation. In this POV, we outline how valuable data from first-party and third-party cookies fuel your paid media strategy as well as your larger digital ecosystem.

Media 59

Media Marketing Healthcare Healthcare 59

PharmExec

DECEMBER 13, 2023

Pfizer Inc. expects to close its $43 billion acquisition of Seagen Inc., on December 14, 2023.

84

84

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

pharmaphorum

DECEMBER 13, 2023

Daiichi Sankyo taps Depixus to speed RNA drug discovery Phil.

102

102

PharmaTech

DECEMBER 13, 2023

Sanofi has issued a statement expressing its disappointment with FTC’s decision to block an exclusive licensing agreement with Maze Therapeutics for a rare disease drug candidate.

52

52

Clarify Health

DECEMBER 13, 2023

To beat the intense competition across the healthcare industry, it’s critical for providers to leverage demand forecasting to accurately forecast future healthcare utilization needs for their services and develop robust roadmaps for growth and success. For healthcare leaders, that means creating strategic plans to minimize patient leakage, relieve financial pressures, and retain and grow the patient populations they serve.

Healthcare 52

Healthcare Healthcare Competition Marketing 52

PharmaTech

DECEMBER 13, 2023

Solubility of the active pharmaceutical ingredient (API) in an oral formulation is critical for absorption from the gastrointestinal (GI) tract and the intended therapeutic effect. Ensuring that an API has the necessary solubility can be challenging for drug developers and formulators. If limitations in solubility cannot be successfully addressed, a new chemical entity (NCE) is unlikely to advance in the development pipeline.

Pharmaceutical 52

Pharmaceutical 52

Advertisement

Distribution

Pharmaceutical Commerce

DECEMBER 13, 2023

MAPS Public Benefit Corporation was previously granted Breakthrough Therapy Designation by the FDA for MDMA and is seeking a priority review for the NDA submission of the psychedelic treatment for post-traumatic stress disorder.

FDA 52

FDA 52

PharmExec

DECEMBER 13, 2023

MAPS Public Benefit Corporation filed a new drug application for MDMA (midomafetamine capsules) for use with psychological intervention for the treatment of post-traumatic stress disorder.

52

52

Pharmaceutical Technology

DECEMBER 13, 2023

Pfizer has obtained all necessary regulatory approvals for concluding the acquisition of biotechnology company Seagen for $43bn in cash.

59

59

PharmaTech

DECEMBER 13, 2023

The new advisory committee will provide the agency with technical and scientific advice and recommendations on potential treatments for genetic metabolic diseases.

FDA 52

FDA 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales